Helen Torley - Feb 16, 2024 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
PRESIDENT AND CEO, Director
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 16, 2024
Transactions value $
-$735,068
Form type
4
Date filed
2/20/2024, 06:49 PM
Previous filing
Feb 16, 2024
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +21K +3.19% $0.00 680K Feb 16, 2024 Direct
transaction HALO Common Stock Tax liability -$408K -11.3K -1.66% $36.10 669K Feb 16, 2024 Direct F1
transaction HALO Common Stock Options Exercise $0 +16.9K +2.52% $0.00 686K Feb 16, 2024 Direct
transaction HALO Common Stock Tax liability -$327K -9.07K -1.32% $36.10 677K Feb 16, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -21K -33.33% $0.00 42K Feb 16, 2024 Common Stock 21K $0.00 Direct F3
transaction HALO Restricted Stock Units Options Exercise $0 -16.9K -25% $0.00 50.6K Feb 16, 2024 Common Stock 16.9K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 11,292 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 The reported disposition of 9,070 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.